1. Home
  2. EARN vs ACHV Comparison

EARN vs ACHV Comparison

Compare EARN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.79

Market Cap

181.1M

Sector

Real Estate

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.63

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
ACHV
Founded
2012
N/A
Country
United States
United States
Employees
160
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.1M
172.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
EARN
ACHV
Price
$4.79
$4.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$14.67
AVG Volume (30 Days)
391.6K
1.2M
Earning Date
06-16-2026
05-11-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.69
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.27
$2.00
52 Week High
$6.08
$6.15

Technical Indicators

Market Signals
Indicator
EARN
ACHV
Relative Strength Index (RSI) 51.80 49.12
Support Level $4.54 $4.04
Resistance Level $5.36 $4.98
Average True Range (ATR) 0.09 0.42
MACD -0.01 -0.10
Stochastic Oscillator 58.55 16.89

Price Performance

Historical Comparison
EARN
ACHV

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: